At least five Indian drug companies — Torrent Pharmaceuticals, Dr Reddy’s Laboratories, Aurobindo Pharma, Cipla and Lupin — are in initial discussions to bid for Sagent Pharmaceuticals, a Nasdaq-listed specialty injectables maker, sources familiar with the talks said. The discussions started about a month ago, they told ET. Sun Pharmaceutical Industries was also interested and had even initiated the due diligence process, but then backed out, mainly over valuation, the sources said. < .. Read more at: http://economictimes.indiatimes.com/articleshow/50711063.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst[printicon align="right"]
Source: Economic TimesTorrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy Sagent.
Industry: Pharmaceutical 2016-01-25